Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
Obesity and MASLD increase risk for youth-onset type 2 diabetes
Children with obesity have increased risk for type 2 diabetes if they are diagnosed with metabolic dysfunction-associated steatotic liver disease, according to findings published in Diabetes Care.
Teens who had bariatric surgery maintain weight loss, diabetes remission 10 years later
A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.
GLP-1 therapy may reduce suicidal ideation risk for adolescents with obesity
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data.
Log in or Sign up for Free to view tailored content for your specialty!
New type 2 diabetes more likely in youth after COVID-19 vs. other respiratory diseases
Children and adolescents diagnosed with COVID-19 were more likely to develop new-onset type 2 diabetes than those who had other respiratory infections, according to data published in JAMA Network Open.
Therapy for congenital hyperinsulinism not approved due to manufacturing issue
The FDA declined to approve a glucagon receptor agonist to treat congenital hyperinsulinism among infants and children, according to an industry press release.
Q&A: Tips for navigating use of diabetes devices in schools
One of many challenges parents face when their child is diagnosed with diabetes is how the condition will be managed in school, particularly if the child is using a diabetes device.
Prediabetes before conception tied to higher risk for adverse pregnancy outcomes
Adolescent and young adult women who had prediabetes before becoming pregnant had a higher risk for gestational diabetes and adverse maternal outcomes than those with normal glycemic levels, researchers reported.
Liraglutide 3 mg reduces BMI for children with obesity aged 6 to 11 years
Children with obesity receiving once-daily liraglutide 3 mg had a greater reduction in BMI at 56 weeks than those receiving placebo, according to data presented at the European Association for the Study of Diabetes annual meeting.
Eating more oats, fruits in early childhood may raise risk for type 1 diabetes
Young children at high genetic risk for type 1 diabetes may be more likely to progress to the disease based on their dietary intake, according to a presenter at the European Association for the Study of Diabetes annual meeting.
Meta Pharmaceuticals receives FDA rare pediatric disease designation for META-001-PH
Meta Pharmaceuticals has received FDA rare pediatric disease designation for its investigational new drug META-001-PH, according to a press release.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read